Publications

Export 35 results:
Author Title Type [ Year(Asc)]
Filters: Keyword is Treatment Outcome  [Clear All Filters]
2016
Lam RW, Milev R, Rotzinger S, Andreazza AC, Blier P, Brenner C, Daskalakis ZJ, Dharsee M, Downar J, Evans KR et al..  2016.  Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort.. BMC Psychiatry. 16:105.
Florian H, Meier A, Gauthier S, Lipschitz S, Lin Y, Tang Q, Othman AA, Robieson WZ, Gault LM.  2016.  Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study.. J Alzheimers Dis. 51(4):1237-47.
Hou L, Heilbronner U, Degenhardt F, Adli M, Akiyama K, Akula N, Ardau R, Arias B, Backlund L, Banzato CEM et al..  2016.  Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study.. Lancet. 387(10023):1085-93.
Sauchelli S, Jiménez-Murcia S, Sánchez I, Riesco N, Custal N, Fernández-García JC, Garrido-Sánchez L, Tinahones FJ, Steiger H, Israel M et al..  2016.  Orexin and sleep quality in anorexia nervosa: Clinical relevance and influence on treatment outcome.. Psychoneuroendocrinology. 65:102-8.
Chaput J-P, Gray CE, Poitras VJ, Carson V, Gruber R, Olds T, Weiss SK, Gorber SConnor, Kho ME, Sampson M et al..  2016.  Systematic review of the relationships between sleep duration and health indicators in school-aged children and youth.. Appl Physiol Nutr Metab. 41(6 Suppl 3):S266-82.
2015
Gauthier S, Proaño JVoltaire, Jia J, Froelich L, Vester JChristophe, Doppler E.  2015.  Cerebrolysin in mild-to-moderate Alzheimer's disease: a meta-analysis of randomized controlled clinical trials.. Dement Geriatr Cogn Disord. 39(5-6):332-47.
Kedzior KKarolina, Gellersen HMarie, Brachetti AKatharina, Berlim M.  2015.  Deep transcranial magnetic stimulation (DTMS) in the treatment of major depression: An exploratory systematic review and meta-analysis.. J Affect Disord. 187:73-83.
McGirr A, Van den Eynde F, Tovar-Perdomo S, Fleck MPA, Berlim M.  2015.  Effectiveness and acceptability of accelerated repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depressive disorder: an open label trial.. J Affect Disord. 173:216-20.
Gauthier S, Rountree S, Finn B, LaPlante B, Weber E, Oltersdorf T.  2015.  Effects of the Acetylcholine Release Agent ST101 with Donepezil in Alzheimer's Disease: A Randomized Phase 2 Study.. J Alzheimers Dis. 48(2):473-81.
Godlewska BR, Near J, Cowen PJ.  2015.  Neurochemistry of major depression: a study using magnetic resonance spectroscopy.. Psychopharmacology (Berl). 232(3):501-7.
Behdinan T, Foussias G, Wheeler AL, Stefanik L, Felsky D, Remington G, Rajji TK, Chakravarty MM, Voineskos AN.  2015.  Neuroimaging predictors of functional outcomes in schizophrenia at baseline and 6-month follow-up.. Schizophr Res. 169(1-3):69-75.
Hunsberger JG, Chibane FL, Elkahloun AG, Henderson R, Singh R, Lawson J, Cruceanu C, Nagarajan V, Turecki G, Squassina A et al..  2015.  Novel integrative genomic tool for interrogating lithium response in bipolar disorder.. Transl Psychiatry. 5:e504.

Pages